Home / Pharma Healthcare / Global Human Coagulation Factor VIII Market by Manufacturers, Regions, Type and Application, Forecast to 2021

Global Human Coagulation Factor VIII Market by Manufacturers, Regions, Type and Application, Forecast to 2021

  • Id : RNR-42980
  • Category : Pharma Healthcare
  • Publish Date : Nov-16
  • Pages : 111
  • Format : PDF
License Type

Description
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A.

Scope of the Report:
This report focuses on the Human Coagulation Factor VIII in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
    Baxter
    Bayer
    CSL
    Pfizer
    Grifols
    Biogen
    Octapharma
    NovoNordisk
    Greencross
    Kedrion
    BPL
    Hualan Bio
    RAAS

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa

Market Segment by Type, covers
    Recombinant Factor VIII
    Plasma-derived Factor VIII

Market Segment by Applications, can be divided into
    Hemophilia A
    Spontanous / Trauma
    Surgical
    Other

There are 13 Chapters to deeply display the global Human Coagulation Factor VIII market.

Chapter 1, to describe Human Coagulation Factor VIII Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Human Coagulation Factor VIII, with sales, revenue, and price of Human Coagulation Factor VIII, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Coagulation Factor VIII, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Human Coagulation Factor VIII market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Human Coagulation Factor VIII sales channel, distributors, traders, dealers, appendix and data source.